APA (7th ed.) Citation

Tang,L., Li,L., Yang,J., & Zeng,C. (2017). Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.

Chicago Style (17th ed.) Citation

Tang,L., Li,L, Yang,J, and Zeng,C. Potential Benefit of (-)-epigallocatechin-3-gallate for Macrovascular Complications in Diabetes. 2017.

MLA (8th ed.) Citation

Tang,L., et al. Potential Benefit of (-)-epigallocatechin-3-gallate for Macrovascular Complications in Diabetes. 2017.

Warning: These citations may not always be 100% accurate.